Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,101–1,200 of 2,883
Changes in the biochemical taste of cytoplasmic and cell-free DNA are major fuels for inflamm-aging
Storci, G., Carolis, S. D., Olivieri, F., & Bonafè, M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.08.003 · Cited by 38
Wang, Y., Wang, Y., Yang, M., & Ma, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111191 · Cited by 34
Frescas, D., Hall, B. M., Strom, E., Virtuoso, L. P., Gupta, M., Gleiberman, A. S., Rydkina, E., Balan, V., Vujcic, S., Chernova, O. B., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339850 · Cited by 34
Is “cellular senescence” a misnomer?
Gems, D., & Kern, C. C. (2022) · GeroScience · doi:10.1007/s11357-022-00652-x · Cited by 35
“The ground-breaking discovery that elimination of p16-positive cells retards development of multiple diseases of aging in mice [6, 55] provided proof for the principle of senotherapy.”
BackgroundInfluentialFernández-Duran, I., Quintanilla, A., Tarrats, N., Birch, J., Hari, P., Millar, F. R., Lagnado, A. B., Smer-Barreto, V., Muir, M., Brunton, V. G., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00917-6 · Cited by 39
Carbon monoxide alleviates senescence in diabetic nephropathy by improving autophagy
Chen, L., Mei, G., Jiang, C., Cheng, X., Li, D., Zhao, Y., Chen, H., Wan, C., Yao, P., Gao, C., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13052 · Cited by 34
The central role of DNA damage in immunosenescence
Kell, L., Simon, A. K., Alsaleh, G., & Cox, L. S. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1202152 · Cited by 49
“Moreover, deletion of senescent cells via genetic (Baker et al., 2016) or pharmacological means [e.”
BackgroundAge-related diseases, therapies and gut microbiome: A new frontier for healthy aging
Barone, M., D’Amico, F., Rampelli, S., Brigidi, P., & Turroni, S. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111711 · Cited by 35
Wang, W., Chen, X., & Cai, G. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111403 · Cited by 39
Grün, L. K., Maurmann, R. M., Scholl, J. N., Fogaça, M. E., Schmitz, C. R. R., Dias, C. K., Gasparotto, J., Padoin, A. V., Mottin, C. C., Klamt, F., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00378-0 · Cited by 38
Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer
Menéndez, J. A., & Alarcón, T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00049 · Cited by 34
Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice
Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230109 · Cited by 41
“To test if Ccl4 + microglia were senescent, we utilized INK-ATTAC transgenic mice bred with tau (creating cohorts of WT;ATTAC and tau;ATTAC ), such that administration of AP20187 (AP) would eliminate p16 INK4a -expressing cells [9, 27, 28].”
Self-citationExploring Senolytic and Senomorphic Properties of Medicinal Plants for Anti-Aging Therapies
Imb, M., Véghelyi, Z., Maurer, M., & Kühnel, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910419 · Cited by 44
“There is strong evidence that senescent cell burden correlates with aging-associated diseases [10,11].”
BackgroundMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 41
Ejaz, A., Mattesich, M., & Zwerschke, W. (2017) · Aging · doi:10.18632/aging.101197 · Cited by 35
TLR9 Mediates Periodontal Aging by Fostering Senescence and Inflammaging
Albuquerque‐Souza, E., Crump, K. E., Rattanaprukskul, K., Li, Y., Shelling, B., Xia, X., Jiang, M., & Sahingur, S. E. (2022) · Journal of Dental Research · doi:10.1177/00220345221110108 · Cited by 43
“p16INK is a well-recognized prosenescence protein that induces an irreversible cell cycle arrest and, consequently, leads to an impaired tissue homeostasis due to the loss of cellular replicative capacity (Baker et al. 2016; Kumari and Jat 2021).”
BackgroundMethodResultInfluentialThe role of lipids in aging-related metabolic changes
de Diego, I., Peleg, S., & Fuchs, B. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.05.005 · Cited by 36
Yilmaz, D., Mathavan, N., Wehrle, E., Kuhn, G. A., & Müller, R. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102118 · Cited by 40
“(Baker et al., 2016; Yousefzadeh et al., 2019). increased 2-month-old of 22-month-old Tfam fl/fl Cd4 observed , these mice in humans Desdin-Mico et al., ability to manifest system, capacity to induce J o u r n a P r e - p r o o Overall, cellular senescence is indeed a contributing factor to…”
Murine models of accelerated aging and musculoskeletal disease
Hambright, W. S., Niedernhofer, L. J., Huard, J., & Robbins, P. D. (2019) · Bone · doi:10.1016/j.bone.2019.03.002 · Cited by 32
Chen, H., Zhou, J., Chen, H., Liang, J., Xie, C., Gu, X., Wang, R., Mao, Z., Zhang, Y., Li, Q., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.574 · Cited by 34
Cellular Senescence Triggers Altered Circadian Clocks With a Prolonged Period and Delayed Phases
Ahmed, R., Nakahata, Y., Shinohara, K., & Bessho, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638122 · Cited by 34
Oda, T., Gotoh, N., Kasamatsu, T., Handa, H., Saitoh, T., & Sasaki, N. (2023) · Cell Proliferation · doi:10.1111/cpr.13398 · Cited by 43
Bruserud, Ø., Vo, A. K., & Reikvam, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030706 · Cited by 43
Shachar, S. S., Deal, A. M., Reeder-Hayes, K. E., Nyrop, K. A., Mitin, N., Anders, C. K., Carey, L., Dees, E. C., Jolly, T. A., Kimmick, G. G., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa082 · Cited by 36
Gervason, S., Napoli, M., Dreux‐Zhiga, A., Lazarelli, C., Garcier, S., Briand, A., Albouy, M., Thepot, A., Berthon, J., & Filaire, E. (2019) · International Journal of Cosmetic Science · doi:10.1111/ics.12534 · Cited by 35
Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
Urate, S., Wakui, H., Azushima, K., Yamaji, T., Suzuki, T., Abe, E., Tanaka, S., Taguchi, S., Tsukamoto, S., Kinguchi, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212432 · Cited by 36
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
Regulation of stem cell aging by SIRT1 – Linking metabolic signaling to epigenetic modifications
An, Y., & Dang, W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.031 · Cited by 33
Chen, J., Chen, K., Wang, L., Luo, J., Zheng, Q., & He, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04972-w · Cited by 42
Circular RNA in Aging and Age-Related Diseases
Yang, D., Yang, K., & Yang, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_2 · Cited by 34
Shin, J.-W., Lee, E., Han, S., Choe, S.-A., & Jeon, O. H. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0024 · Cited by 32
Multiparameter flow cytometric detection and quantification of senescent cells in vitro
Adewoye, A. B., Tampakis, D., Follenzi, A., & Stolzing, A. (2020) · Biogerontology · doi:10.1007/s10522-020-09893-9 · Cited by 33
Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease
Horowitz, A. M., & Villeda, S. A. (2017) · F1000Research · doi:10.12688/f1000research.11437.1 · Cited by 32
Franco, A. C., Martini, H., Victorelli, S. G., Lagnado, A. B., Wyles, S. P., Rowsey, J. L., Pirius, N., Woo, S., Costa, D. G., Chaib, S., et al. (2024) · Aging Cell · doi:10.1111/acel.14340 · Cited by 38
Todhunter, M. E., Sayaman, R. W., Miyano, M., & LaBarge, M. A. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.016 · Cited by 33
Friends and foes: Extracellular vesicles in aging and rejuvenation
Lananna, B. V., & Imai, S. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00077 · Cited by 35
Why stem/progenitor cells lose their regenerative potential
Picerno, A., Stasi, A., Franzin, R., Curci, C., di Bari, I., Gesualdo, L., & Sallustio, F. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i11.1714 · Cited by 36
Geroscience: A Translational Review
Kritchevsky, S. B., & Cummings, S. R. (2025) · JAMA · doi:10.1001/jama.2025.11289 · Cited by 52
Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice
Ota, H., & Kodama, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-06448-5 · Cited by 34
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
“Intervention experiments have proven that senescent cell accumulation is an important driver of age-associated functional decline, (multi-)morbidity, and mortality [8].”
BackgroundInfluentialStojiljkovic, M. R., Schmeer, C. W., & Witte, O. W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.02.018 · Cited by 33
Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 44
Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP)
Malaquin, N., Tu, V., & Rodier, F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_6 · Cited by 39
Ding, Z., Ma, G., Zhou, B., Cheng, S., Tang, W., Han, Y., Chen, L., Pang, W., Chen, Y., Yang, D., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101665 · Cited by 42
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
Rybtsova, N., Berezina, T. N., Kagansky, A., & Александрович, Р. С. (2020) · Biomedicines · doi:10.3390/biomedicines8120615 · Cited by 36
Rejuvenating subventricular zone neurogenesis in the aging brain
Cutler, R. R., & Kokovay, E. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.10.005 · Cited by 31
Mitochondrial RNA cytosolic leakage drives the SASP
Victorelli, S. G., Eppard, M., Martini, H., Woo, S., Everts, S. P. A., Lee, G., Pirius, N., Han, N., Liang, E. Y., Franco, A. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66159-z · Cited by 53
Insight into the Role of Angiopoietins in Ageing-Associated Diseases
Hayashi, S.-I., Rakugi, H., & Morishita, R. (2020) · Cells · doi:10.3390/cells9122636 · Cited by 34
Dong, Q., Wei, L., Zhang, M. Q., & Wang, X. (2018) · Aging · doi:10.18632/aging.101485 · Cited by 36
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome
(2024) · doi:10.1038/s43587-024-00695-z · Cited by 31
Caland, L., Labbé, P., Mamarbachi, M., Villeneuve, L. R., Ferbeyre, G., Noly, P., Carrier, M., Thorin‐Trescases, N., & Thorin, É. (2019) · Aging · doi:10.18632/aging.102020 · Cited by 37
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
“Cellular senescence is a hallmark of ageing 20 : senescent cells not only accumulate during ageing 21 but contribute to ageing and age-related diseases 22 .”
BackgroundHisamatsu, D., Ohno‐Oishi, M., Nakamura, S., Mabuchi, Y., & Naka-Kaneda, H. (2016) · Aging · doi:10.18632/aging.100982 · Cited by 34
Sasaki, M., Sato, Y., & Nakanuma, Y. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102377 · Cited by 33
Mesenchymal stromal cell senescence in haematological malignancies
Plakhova, N., Panagopoulos, V., Vandyke, K., Zannettino, A. C. W., & Mrozik, K. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10069-9 · Cited by 36
“For instance, studies in mice expressing the INK-ATTAC transgene enabling the elimination of p16INK4a-expressing senescent cells have shown that global clearance of senescent cells from aged mice is able to delay tumourigenesis and prevent age-related deterioration of organs such as the kidney, heart, and adipose tiss…”
BackgroundSalamander Insights Into Ageing and Rejuvenation
Yun, M. H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.689062 · Cited by 36
HMGB2 holds the key to the senescence-associated secretory phenotype
Guerrero, A., & Gil, J. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201610044 · Cited by 30
Ali, I., Zhang, H., Zaidi, S. A. A., & Zhou, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102273 · Cited by 41
Sieben, C. J., Jeganathan, K. B., Nelson, G. G., Sturmlechner, I., Zhang, C., van Deursen, W. H., Bakker, B., Foijer, F., Li, H., Baker, D. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126863 · Cited by 30
Self-citationA nutrigeroscience approach: Dietary macronutrients and cellular senescence
Calubag, M. F., Robbins, P. D., & Lamming, D. W. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.025 · Cited by 35
p16High senescence restricts cellular plasticity during somatic cell reprogramming
Grigorash, B. B., van Essen, D., Liang, G., Grosse, L., Emelyanov, A., Kang, Z., Korablev, A. N., Kanzler, B., Molina, C., Lopez, E., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01214-9 · Cited by 35
Age-related Changes in the Adrenal Cortex: Insights and Implications
Warde, K. M., Smith, L., & Basham, K. J. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad097 · Cited by 34
“Given that ablation of p16-positive senescent cells alleviates numerous age-associated diseases [115, 116], it would be interesting to further explore the role of p16 in the aged adrenal.”
BackgroundRegulation of cellular senescence by microRNAs
Ma, X., Zheng, Q., Zhao, G., Yuan, W., & Liu, W. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111264 · Cited by 30
Distinct types of stem cell divisions determine organ regeneration and aging in hair follicles
Matsumura, H., Liu, N., Nanba, D., Ichinose, S., Takada, A., Kurata, S., Morinaga, H., Mohri, Y., Arcangelis, A. D., Ohno, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00033-7 · Cited by 37
Yang, J.-J., Zhao, S.-L., Zhang, X., Ma, Y., & Jiang, J. (2023) · Industrial Crops and Products · doi:10.1016/j.indcrop.2023.116903 · Cited by 30
Jin, H., Zhang, Y., Liu, D., Wang, S. S., Ding, Q. J., Rastogi, P., Purvis, M., Wang, A., El-Hadi, S., Ren, C., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.013 · Cited by 34
Jang, H.-J., Yang, K. E., Oh, W. K., Lee, S.-I., Hwang, I.-H., Ban, K.-T., Yoo, H.-S., Choi, J.-S., Yeo, E.-J., & Jang, I.-S. (2019) · Aging · doi:10.18632/aging.102013 · Cited by 30
“Reduced expression of senescence markers can reverse cellular senescence, resulting in extended lifespan and delayed development of aging-associated diseases [5].”
BackgroundTelomeres: beacons of autocrine and paracrine DNA damage during skin aging
Victorelli, S. G., & Passos, J. F. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1728016 · Cited by 36
Nano-Based Theranostic Tools for the Detection and Elimination of Senescent Cells
Adamczyk‐Grochala, J., & Lewińska, A. (2020) · Cells · doi:10.3390/cells9122659 · Cited by 32
Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
Hussain, M. S., Agrawal, N., Ilma, B., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Gupta, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70503 · Cited by 37
Aging as a loss of morphostatic information: A developmental bioelectricity perspective
Pio‐Lopez, L., & Levin, M. G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102310 · Cited by 41
Espinoza, S. E., Khosla, S., Baur, J. A., de Cabo, R., & Musi, N. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad034 · Cited by 34
miR-1468-3p Promotes Aging-Related Cardiac Fibrosis
Lin, R., Rahtu‐Korpela, L., Magga, J. M., Ulvila, J., Swan, J., Kemppi, A., Pakanen, L., Porvari, K., Huikuri, H. V., Junttila, J. M., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.001 · Cited by 31
Age-related dysfunction of the DNA damage response in intestinal stem cells
Watanabe, K., Ikuno, Y., Kakeya, Y., Ikeno, S., Taniura, H., Kurono, M., Minemori, K., Katsuyama, Y., & Naka-Kaneda, H. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0096-y · Cited by 31
An Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404885 · Cited by 33
Promises and challenges of senolytics in skin regeneration, pathology and ageing
Pils, V., Ring, N., Valdivieso, K., Lämmermann, I., Грубер, Ф., Schosserer, M., Grillari, J., & Ogrodnik, M. B. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111588 · Cited by 34
Mixing old and young: enhancing rejuvenation and accelerating aging
Lau, A., Kennedy, B. K., Kirkland, J. L., & Tullius, S. G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123946 · Cited by 29
Bechshøft, C. J. L., Jensen, S. M., Schjerling, P., Andersen, J. L., Svensson, R. B., Eriksen, C. S., Mkumbuzi, N. S., Kjær, M., & Mackey, A. L. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00049.2019 · Cited by 34
Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice
Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230465 · Cited by 35
“INK-ATTAC mice expressadrug-inducibleCaspase8moleculethatpro-motescelldeathinp16-expressingcellswhentreated withAP[4,6,7].”
Self-citationJi, C., Wei, C., Li, M., Shen, S., Zhang, S., Hou, Y., & Wu, Y. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2131839 · Cited by 34
“P16INK4a is a key factor in cell cycle arrest (Baker et al. 2011, 2016), and PCNA is a gene related to the cell cycle (Lei et al. 2021).”
BackgroundBi, S., Wang, H., & Kuang, W. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.005 · Cited by 28
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16INK4A
Göbl, C., Morris, V. K., van Dam, L., Visscher, M., Polderman, P. E., Hartlmüller, C., de Ruiter, H., Hora, M., Liesinger, L., Birner-Gruenberger, R., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101316 · Cited by 29
Farooq, U., Saravanan, B., Islam, Z., Walavalkar, K., Singh, A. K., Jayani, R. S., Meel, S., Swaminathan, S., & Notani, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108898 · Cited by 29
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 35
Roggério, A., Strunz, C. M. C., Pacanaro, A. P., Leal, D. P., Takada, J. Y., Avakian, S. D., & Mansur, A. D. P. (2018) · Nutrients · doi:10.3390/nu10070937 · Cited by 30
Ahmed, R., Ashimori, A., Iwamoto, S., Matsui, T., Nakahata, Y., & Bessho, Y. (2019) · Aging · doi:10.18632/aging.101794 · Cited by 32
He, Z., Chen, Y., Hou, C., He, W., & Chen, P. (2017) · Medical Science Monitor · doi:10.12659/msm.902746 · Cited by 29
Novel therapeutic approaches to target neurodegeneration
de la Fuente, A. G., Pelucchi, S., Mertens, J., Luca, M. D., Mauceri, D., & Marcello, E. E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16078 · Cited by 33
Salech, F., SanMartín, C. D., Concha-Cerda, J., Romero-Hernández, E., Ponce, D. P., Liabeuf, G., Rogers, N. K., Murgas, P., Bruna, B., More, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169387 · Cited by 29
Okuno, K., Cicalese, S. M., Elliott, K. J., Kawai, T., Hashimoto, T. N., & Eguchi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186579 · Cited by 29
Kuehnemann, C., Hughes, J. B., Desprez, P., Melov, S., Wiley, C. D., & Campisi, J. (2022) · Aging Cell · doi:10.1111/acel.13750 · Cited by 28
Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models
Zonari, A. A. C., Brace, L. E., Al-Katib, K., Porto, W. F., Foyt, D. A., Guiang, M., Cruz, E. A. O., Marshall, B., Salgueiro, W. G., Inan, M. D., et al. (2023) · npj Aging · doi:10.1038/s41514-023-00109-1 · Cited by 53
“Senescent cells were previously considered to only be byproducts of tissue aging, but more recent studies demonstrate them to be active inducers of aging and dysfunction 1,8,9 , justifying the need for the development of senotherapeutic approaches to treat aging-related diseases.”
BackgroundKidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies
Saritas, T., & Kramann, R. (2021) · Transplantation · doi:10.1097/tp.0000000000003678 · Cited by 32
Rejuvenation of aged hematopoietic stem cells
Guidi, N., & Geiger, H. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.005 · Cited by 30
Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction
Tobin, S. W., Alibhai, F. J., Weisel, R. D., & Li, R. (2020) · Cells · doi:10.3390/cells9081894 · Cited by 35
Gao, L., Slack, M. A., McDavid, A., Anolik, J. H., & Looney, R. J. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0800-6 · Cited by 33
Ueno, D., Ikeda, K., Yamazaki, E., Katayama, A., Urata, R., & Matoba, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35447-3 · Cited by 35
Therapeutic Antiaging Strategies
Mishra, S. K., Balendra, V., Esposto, J., Obaid, A. A., Maccioni, R. B., Jha, N. K., Perry, G. L., Moustafa, M., Al-Shehri, M., Singh, M. P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102515 · Cited by 36
Li, J., Karim, M. A., Che, H., Geng, Q., & Miao, D. (2020) · PubMed · doi:10.6094/unifr/166811 · Cited by 36
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.